The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide survey in Karnataka, India
Implementing Organization
Indian Institute of Science
Principal Investigator
Prof Giridhara R Babu
Public Health Foundation of India
CO-Principal Investigator
Prof Rajesh Sundaresan
Indian Institute of Science
About
The routinely used case-based reporting and IgG serosurveys underestimate the actual prevalence of COVID-19. Simultaneous estimation of IgG antibodies and active SARS-CoV2 markers can provide a more accurate estimation. This is the first comprehensive survey providing accurate estimates of the COVID-19 burden.
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.